1. Home
  2. IMNN vs AWX Comparison

IMNN vs AWX Comparison

Compare IMNN & AWX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Imunon Inc.

IMNN

Imunon Inc.

N/A

Current Price

$2.88

Market Cap

11.5M

Sector

Health Care

ML Signal

N/A

AWX

Avalon Holdings Corporation

N/A

Current Price

$2.49

Market Cap

10.3M

Sector

Utilities

ML Signal

N/A

Company Overview

Basic Information
Metric
IMNN
AWX
Founded
1982
1998
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Environmental Services
Sector
Health Care
Utilities
Exchange
Nasdaq
Nasdaq
Market Cap
11.5M
10.3M
IPO Year
2000
1998

Fundamental Metrics

Financial Performance
Metric
IMNN
AWX
Price
$2.88
$2.49
Analyst Decision
Buy
Analyst Count
2
0
Target Price
$10.00
N/A
AVG Volume (30 Days)
37.7K
4.6K
Earning Date
05-11-2026
05-11-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
$53,090,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
3.14
52 Week Low
$0.37
$2.10
52 Week High
$9.32
$5.43

Technical Indicators

Market Signals
Indicator
IMNN
AWX
Relative Strength Index (RSI) 39.79 36.31
Support Level $2.52 $2.42
Resistance Level $3.24 $2.64
Average True Range (ATR) 0.16 0.04
MACD -0.01 -0.01
Stochastic Oscillator 13.95 17.43

Price Performance

Historical Comparison
IMNN
AWX

About IMNN Imunon Inc.

Imunon Inc is a clinical-stage biotechnology company focused on advancing a portfolio of treatments that harness the body's natural mechanisms to generate safe, effective and durable responses across a broad array of human diseases, constituting a differentiating approach from conventional therapies. It is developing its non-viral DNA technology across its modalities. The first modality, TheraPlas, is developed for the coding of proteins and cytokines in the treatment of solid tumors. The second modality, PlaCCine, is developed for the coding of viral antigens that can elicit an immunological response. The company's clinical program, IMNN-001, is a DNA-based immunotherapy for the localized treatment of ovarian cancer.

About AWX Avalon Holdings Corporation

Avalon Holdings Corp is a waste management company. The company provides waste management services to industrial, commercial, municipal, and governmental customers in selected northeastern and midwestern U.S. markets. The company has two operating segments. The Waste management services segment which is the key revenue driver, includes waste disposal services, captive landfill operations, and saltwater injection well operations. Its Golf and related operations segment includes management of golf courses and related clubhouses, a hotel, fitness centers, tennis courts, salon and spa services, dining, banquet, and conference facilities.

Share on Social Networks: